| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | EVP, Cell &Genetic Therapies
2 companies
Sanna Bastiano is an EVP, Cell &Genetic Therapies at VERTEX PHARMACEUTICALS INC / MA with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 30 sells.
Estimated insider holdings value: $14.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 8, 2023 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Cell &Genetic Therapies | Sell | 3,272 | $350.00 | $1,145,212.66 | -4.7% | +0.4% | +19.2% | |
| May 3, 2023 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Cell &Genetic Therapies | Sell | 4,403 | $350.71 | $1,544,186.50 | -2.3% | +0.4% | +15.5% | |
| Apr 12, 2023 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Cell &Genetic Therapies | Sell | 7,567 | $326.70 | $2,472,164.15 | -5.6% | +4.7% | +22.6% | |
| Apr 4, 2023 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Cell &Genetic Therapies | Sell | 522 | $315.81 | $164,854.34 | -0.2% | +10.5% | +30.0% | |
| Mar 16, 2023 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Cell &Genetic Therapies | Sell | 2,746 | $300.59 | $825,422.76 | -2.7% | +13.4% | +35.6% | |
| Feb 14, 2023 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Cell &Genetic Therapies | Sell | 2,181 | $300.39 | $655,161.27 | -1.8% | +16.1% | +39.2% | |
| Feb 13, 2023 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Cell &Genetic Therapies | Sell | 113 | $300.39 | $33,944.07 | -0.2% | +16.5% | +39.1% | |
| Jan 31, 2023 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Cell &Genetic Therapies | Sell | 106 | $325.00 | $34,450.00 | -0.3% | +6.8% | +34.1% | |
| Nov 2, 2022 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Cell &Genetic Therapies | Sell | 320 | $312.64 | $100,045.10 | -0.1% | +4.2% | +21.5% | |
| Oct 18, 2022 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Cell &Genetic Therapies | Sell | 1,791 | $300.31 | $537,859.98 | -2.2% | +3.9% | +22.4% |